Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Destiny Pharma. Share Price
  4. Destiny Pharma. Share Regulatory News
  5. Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections

Pin to quick picksDestiny Pharma. Regulatory News (DEST)

Destiny Pharma. Information

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.25%)
Open: 16.50
High: 16.50
Low: 16.50
Prev. Close: 16.50
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections

21 Nov 2022 14:20

Destiny Pharma PLC Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections 21.11.2022 / 15:19 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

21.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:Destiny Pharma PLC
United States
ISIN:GB00BDHSP575
EQS News ID:1492837
 
End of NewsEQS News Service

1492837 21.11.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12345
Date   Source Headline
9th May 20242:35 pmRNSPosting of Annual Report and Notice of AGM
25th Apr 20247:00 amRNSFull year results and review of strategic options
8th Apr 20247:00 amRNSNotice of Full Year Results
19th Mar 20242:47 pmRNSExercise of Options and Total Voting Rights
31st Jan 20247:00 amRNSClinical development update
22nd Jan 20247:00 amRNSAppointment of Nominated Adviser and Sole Broker
4th Jan 20247:00 amRNSYear End Business Update
20th Oct 20237:00 amRNSGrant of Share Options
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:01 amRNSXF Pipeline Update Meeting
17th Oct 20237:00 amRNSPublication of new microbiological data for XF-73
10th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 202312:34 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSNotice of XF Pipeline Update Meeting
20th Sep 20237:00 amRNSInterim Results
23rd Aug 20237:00 amRNSNotice of Interim Results
31st Jul 202312:01 pmRNSPublication of new data for XF-73
25th Jul 20237:00 amRNSAppointment of new Chairman
19th Jul 202312:55 pmRNSBoard changes including appointment of new CEO
7th Jul 20237:00 amRNSExercise of Options and Total Voting Rights
6th Jul 20237:00 amRNSPositive findings from recent SAB meeting
29th Jun 20237:00 amRNSBusiness Update
26th May 20233:27 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSDirector Dealing
25th May 202312:23 pmRNSResult of Annual General Meeting
25th May 20237:00 amRNSDr Debra Barker Appointed Interim CEO
12th May 202312:24 pmRNSGrant of Share Options
2nd May 20237:00 amRNSPositive results from SPOR-COV® research
26th Apr 20234:10 pmRNSPosting of Annual Report and Notice of AGM
26th Apr 202310:05 amRNSExercise of Options and Total Voting Rights
13th Apr 20237:00 amRNSAudited results for year ended 31 December 2022
4th Apr 20237:00 amRNSLandmark data published on NTCD-M3
3rd Apr 20237:00 amRNSNotice of Results and Investor Presentation
24th Mar 20237:00 amRNSLandmark XF-73 Phase 2 data published in journal
16th Mar 20233:29 pmRNSResult of General Meeting and Total Voting Rights
15th Mar 20234:02 pmRNSResult of Open Offer
6th Mar 202310:50 amRNSExercise of Options and Total Voting Rights
6th Mar 202310:31 amRNSHolding(s) in Company
28th Feb 20233:55 pmRNSPosting of Circular and Notice of General Meeting
27th Feb 20234:30 pmRNSDirector/PDMR Shareholding
24th Feb 20231:32 pmRNSIssue of Equity
24th Feb 20231:32 pmRNSAgreement with Sebela Pharmaceutical for NTCD-M3
24th Feb 202311:00 amRNSPrice Monitoring Extension
31st Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 202310:10 amRNSExercise of Options and Total Voting Rights
25th Jan 20237:00 amRNSUS Center for Disease Control review paper
22nd Dec 20229:05 amRNSSecond Price Monitoring Extn
22nd Dec 20229:00 amRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSYear End Trading Update
7th Dec 20227:00 amRNSFDA/CDC highlight need for infection preventions
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.